---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-031093"
form_type: "8-K"
ticker: "NUWE"
cik: "0001506492"
company_name: "Nuwellis, Inc."
filed_at: "2025-08-14T23:59:59+00:00"
generated_at: "2026-05-17T13:07:32.821186+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Nuwellis Q2 2025 revenue down 23% YoY to $1.7M; net loss widens to $12.6M

## Summary
- Revenue $1.7M vs $2.2M in Q2 2024; decline due to sterilization vendor backorder.
- Gross margin fell to 55.5% from 67.2%; operating loss $2.9M vs $2.3M.
- Net loss attributable to common shareholders $12.6M ($60.99/share) vs $7.7M ($791.82).
- Cash $4.5M; debt-free; completed $5.0M gross capital raise in Q2.
- Outsourced manufacturing to KDI Precision; added two pediatric centers (47 total); new patent on fluid bag design.

## SEC filing metadata
- accession: 0001140361-25-031093
- form_type: 8-K
- ticker: NUWE
- cik: 0001506492
- company_name: Nuwellis, Inc.
- filed_at: 2025-08-14T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506492/000114036125031093/0001140361-25-031093-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506492/000114036125031093/ef20053865_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-031093
- JSON: https://secwatch.observer/filing/0001140361-25-031093.json
- Plain text: https://secwatch.observer/filing/0001140361-25-031093.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.